Back to search

Article

Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based, Review

2023-10-17

Abstract excerpt

Dual antiplatelet therapy (DAPT), comprising aspirin and a P2Y12 receptor inhibitor, is the cornerstone of post-percutaneous coronary intervention treatment to prevent stent thrombosis and reduce the risk of adverse cardiovascular events. The selection of an optimal DAPT regimen, considering the interplay of various antiplatelet agents, patient profiles, and procedural characteristics, remains an evolving challeng...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2ba462bc-4630-5336-9613-5640caaa749c
DOI
10.20944/preprints202310.1026.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based, ReviewDOI 10.20944/preprints202310.1026.v1
Dual antiplatelet therapy in patients with coronary artery disease after percutaneous coronary intervention with drug-eluting stents: A systematic review and network meta-analysisSemantic proximity
Practice Pattern and Prognostic Effect of Dual Antiplatelet Therapy for Left Main Coronary Artery DiseaseSemantic proximity
Initial ticagrelor monotherapy strategy is effective and safe in patient with high bleeding risk after percutaneous coronary intervention: series case reports and literature reviewSemantic proximity
Safety considerations with the use of platelet inhibitors for elderly patients with non-ST- elevation acute coronary syndrome.Semantic proximity
Effect of pharmacogenomics - oriented Dual Antiplatelet Therapy Followed by P2Y12 receptor inhibitors/Aspirin on Cardiovascular and Bleeding Events in ACS Patients: A Trial ProtocolSemantic proximity
Innovations of Diagnosis and Treatment of Coronary Artery DiseaseSemantic proximity
Antiplatelet treatment for coronary heart diseaseSemantic proximity
Guided antiplatelet therapy with P2Y12 antagonists in patients undergoing percutaneous coronary intervention: 3 systematic reviews with meta-analyses of randomized controlled trials with homogeneous designSemantic proximity
Genotype- and phenotype-directed antiplatelet therapy selection in patients with acute coronary syndromes.Semantic proximity
Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: A longitudinal cohort studySemantic proximity
Comparison of the safety and efficacy of between second-generation and first-generation drug eluting stents in patients with left main coronary artery stenosis: A systematic review and meta-analysisSemantic proximity
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry.Semantic proximity
Select a neighboring publication to make it the new centre.